Hospital Mutua de Terrassa   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Terrassa Spain (1900)

Organization Overview

First Clinical Trial
2004
NCT00429975
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Hospital Mútua Terrassa | Hospital Mutua de Terrassa | Hospital Mutua de Terrassa. Neurology Department | Hospital Mutua Terrassa | HOSPITAL MUTUA TERRASSA | Hospital Universitari Mútua Terrassa

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 3)

Meningitis (Phase 4)

Meningitis, Pneumococcal (Phase 4)

Osteoarthritis, Hip (Phase 4)

Pneumonia (Phase 4)

Pneumonia, Pneumococcal (Phase 4)

Pulmonary Disease, Chronic Obstructive (Phase 4)

Seizures (Phase 4)

Stroke (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 10